Compare LONA & PEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LONA | PEW |
|---|---|---|
| Founded | 2011 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.7M | 56.7M |
| IPO Year | 2020 | 2025 |
| Metric | LONA | PEW |
|---|---|---|
| Price | $4.35 | $1.89 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $16.67 | N/A |
| AVG Volume (30 Days) | 82.9K | ★ 395.5K |
| Earning Date | 11-17-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $96,449,000.00 |
| Revenue This Year | N/A | $6.38 |
| Revenue Next Year | N/A | $6.53 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.57 |
| 52 Week Low | $2.21 | $1.79 |
| 52 Week High | $14.21 | $4.45 |
| Indicator | LONA | PEW |
|---|---|---|
| Relative Strength Index (RSI) | 39.17 | 51.81 |
| Support Level | $4.39 | $1.79 |
| Resistance Level | $9.78 | $2.20 |
| Average True Range (ATR) | 0.45 | 0.12 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 2.87 | 57.50 |
LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.
GrabAGun Digital Holdings Inc is a multi-brand eCommerce retailer of firearms, ammunition and related accessories. The Company's firearm products are ordered and paid for by customers online through the Company's eCommerce site and mobile app and are delivered to them on-premises through their choice of federal firearm licensed dealers nationwide. The Company's network of localized firearm dealers perform background checks on firearms purchasers and complete sales forms as mandated by federal and state firearm regulations.